Dienone compounds: targets and pharmacological responses
M Bazzaro, S Linder - Journal of medicinal chemistry, 2020 - ACS Publications
The biological responses to dienone compounds with a 1, 5-diaryl-3-oxo-1, 4-pentadienyl
pharmacophore have been studied extensively. Despite their expected general thiol …
pharmacophore have been studied extensively. Despite their expected general thiol …
Structure-function analyses of candidate small molecule RPN13 inhibitors with antitumor properties
We sought to design ubiquitin-proteasome system inhibitors active against solid cancers by
targeting ubiquitin receptor RPN13 within the proteasome's 19S regulatory particle. The …
targeting ubiquitin receptor RPN13 within the proteasome's 19S regulatory particle. The …
Chirality and asymmetry increase the potency of candidate ADRM1/RPN13 inhibitors
RK Anchoori, L George, SH Tseng, B Lam… - Plos one, 2021 - journals.plos.org
Bortezomib and the other licensed 20S proteasome inhibitors show robust activity against
liquid tumors like multiple myeloma, but have disappointed against solid tumors including …
liquid tumors like multiple myeloma, but have disappointed against solid tumors including …
Evaluation of anti-inflammatory diphenyldihaloketone EF24 in transient ischemic stroke model
Objectives Revascularization is necessary in patients with ischemic stroke, however it does
not address inflammation that contribute to reperfusion injury and the early growth of …
not address inflammation that contribute to reperfusion injury and the early growth of …
Therapeutic Investigation of CLEFMA in a Murine Model of Intestinal Ischemia-Reperfusion Injury
D Marchi - 2022 - search.proquest.com
Intestinal ischemic-reperfusion injury (IRI) occurs when vascular blood flow is interrupted in
the mesenteric vessels, followed by reperfusion when blood flow is re-established to the …
the mesenteric vessels, followed by reperfusion when blood flow is re-established to the …
Differential oxidative and pro-apoptotic response of cancer and normal cells to an anti-inflammatory agent CLEFMA
Selective killing of cancer cells by chemotherapy has been an age old challenge, but certain
unique features of cancer cells allow discriminatory response between cancer and normal …
unique features of cancer cells allow discriminatory response between cancer and normal …
Small molecule rpn13 inhibitors with antitumor properties
RBS Roden, RK Anchoori - US Patent App. 17/781,507, 2023 - Google Patents
C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with
other rings, with one nitrogen atom as the only ring hetero atom and three or more double …
other rings, with one nitrogen atom as the only ring hetero atom and three or more double …